Columbia Labs Sued Over Drug-Related Stock Drop
Pharmaceutical company Columbia Laboratories Inc., whose touted premature-birth-preventing drug recently failed to win a key U.S. approval, was hit with a class action Friday by an investor who claims he was...To view the full article, register now.
Already a subscriber? Click here to view full article